Three Day International Symposium On Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios

IIPRD (Institute of Intellectual Property Research & Development) is happy to announce its International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios. Presentation of all-important patent issues such as identification of potential inventions, Biosimilar Legislation, preparation of claim sets, prosecution and examination practices, drafting of responses of Office Actions, ANDA Litigation, and recent case law updates can be expected at the symposium.

The three-day international symposium will be held at Hotel Hilton, Mumbai from 16th – 18th Sept’ 2012. IIPRD is organizing the international symposium with the help of international law firms Sughrue Mion PLLC, USA, Hoffman Eitle, Europe and Khurana & Khurana, Advocates, and IP Attorneys, India.

Key speakers include

  1. Dr. Stephan Disser from Hoffman Eitle, Europe
  2. Dr. Leonard Werner-Jones from Hoffman Eitle, Europe
  3. Mr. Chid Iyer from Sughrue Mion, USA
  4. Ms. Renita S. Rathinam from Sughrue Mion, USA
  5. Mr. Michael R Dzwonczyk from Sughrue Mion, USA
  6. Dr. William Simmons from Sughrue Mion, USA
  7. Ms. Azy Kokabi from Sughrue Mion, USA
  8. Mr. Tarun Khurana from Khurana and Khurana, Advocates and IP attorneys, India

The speakers are a unique gathering of Patent Attorneys, who have extensive years of experience in their professional fields, and will put across to the delegates the real insight of Patent Laws and Practices as prevalent and practiced in United States. The Workshop will provide an opportunity to receive first-hand information including recent Judgment on various issues from the experts in the fields. The speakers are selected such that the attendees can get to know the real insight and nitty-gritty followed at United States. The speakers would share real-life cases and experiences that can help the attendees in following the best practices for building their respective patent portfolios. The speakers would also talk at length on the recent case laws and how courts of different geographies interpret the same application in different ways so that best practices for each geography can be put across.

About the Organizers:

IIPRD is a premier IP Consulting and Licensing Firm with a diversified business practice providing services in the domain of Commercialization, Valuation, Licensing, Transfer of Technology and Due-Diligence of Intellectual Property Assets along with providing complete IP and Patent Analytics and Litigation Support Services to Indian and International Corporates and Global Law Houses. IIPRD has been established precisely to assist the business houses in strategizing their growth by leveraging their IPR’s through effective Creation, Promotion, Protection, and Commercialization of IP. IIPRD has been a part of a large number of Out-Licensing deals for technology companies in Pharmaceutical and Hi-Technology domains such as NCE’s, Formulations, and Process Patents in Pharma domain and Telecommunication/Network and Green Technologies. IIPRD has a legacy of twelve years of existence and is among the first Indian IP Firms to have a core focus on Commercialization, Technology Transfer, and Licensing for numerous Indian and Global Corporate.

Hoffmann Eitle, founded in 1892, is not only one of the oldest but also one of the largest intellectual property law firms in Europe with a team of about 100 professionals and more than 300 total staff. The professionals include patent attorneys, attorneys-at-law, and technical specialists. Hoffmann Eitle is consistently ranked as a top tier firm in intellectual property in relevant lawyers’ handbooks such as Chambers (Europe) and The Legal 500 (Europe and Germany). In 2010, Hoffmann Eitle received the JUVE award as the German Firm of the Year in intellectual property and patent law. Hoffmann Eitle handles all technological fields and legal aspects of intellectual property law. The firm has earned its excellent reputation by maintaining very high standards over decades, as is best illustrated by its success in international and pan-European prosecution work and in the litigation of any intellectual property rights for numerous companies ranging from small and medium-sized companies to major international corporations. Based in Munich and London, Hoffmann Title is able to provide competent advice on the two most important (and intrinsically different) legal systems in Europe. With an office also in Milan and having, in addition to German and British patent attorneys, Italian, Dutch, Belgian, and Spanish patent attorneys in its team of professionals, Hoffmann Eitle is able to cover several important national European jurisdictions as well.

Sughrue Mion PLLC is one of the world’s leading intellectual property law firms managing traditional and non-traditional intellectual property rights, for about five decades, with a wide range of clients around the world. Sughrue’s more than 100 lawyers protect ideas- all ideas- and for the last 50 years have been helping their clients to develop, obtain, protect and leverage their intellectual property rights in technology areas ranging from a submicroscopic sequence of DNA to a vast constellation of satellites circling the globe. Sughrue’s Pharmaceuticals, Biotechnology, Chemical attorneys are trained in technical disciplines that include molecular and cellular biology, biophysics, pharmaceuticals, chemistry, immunology, virology, genetics, and agriculture biotechnology. Their experts are particularly well versed in drafting claims to ensure the broadest possible coverage and have long-established expertise in handling patent interference proceedings that may be critical to determining basic patent rights in new areas of biotechnological and pharmaceutical industries. Their litigators who specialize in chemistry have tried cases relating to pharmaceuticals, biotechnology, industrial chemical processes, specialty chemicals, and nanotechnology. Sughrue Mion handles a wide range of IP litigation matters for clients around the world, and when it comes to serving their clients, they go beyond traditional boundaries, advocating innovative theories and redefining the frontiers of law as they apply to creativity and invention.

Khurana & Khurana is more than a full-service IP Law firm and is among the youngest Indian IP Law firms to have been ranked and recommended by Legal 500 and Managing IP. K & K was formed in the year 2006 with the very focus of providing End-to-End IP Legal Services along with its Sister Concern IIPRD, which supplement each other in order to provide end-to-end services to the corporate world in the IP Field. K & K and IIPRD, through their team of over 40 IP Attorneys and Practitioners, together form a niche in the IP domain by taking any corporate from the stage of IP Creation and Protection through its team of Attorneys to the stage of IP Valuation, Licensing, and Commercialization. Team of IP Attorneys/Practitioners having a high level of technical and legal competence gives the right competitive edge and positioning to K & K as a law firm focused on creating immense IP value for its clients. K & K today represents global Corporates across geographies and technology domains and helps then successfully enforce, litigate, and protect their IP Portfolio in India.

Leave a Reply

Your email address will not be published. Required fields are marked *

2 × five =

Archives

  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • September 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010